Enteral Feeding Devices Market to Surpass US$ 4,853.8 Million by 2027 - Coherent Market Insights

Global Enteral Feeding Devices Market, By Product Type (Feeding Tubes (Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube (Nasojejunal, Nasoduodenal), Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector (PEG (Percutaneous Endoscopic Gastrostomy) Tube, PRG (Percutaneous Radiologic Gastrostomy) Tube, Button Tubes), Jejunostomy Tubes (PEJ (Percutaneous Endoscopic  Jejunostomy) Tube, PRJ (Percutaneous Radiologic Jejunostomy) Tube), Feeding Pumps (Peristaltic Silicone), Administration Reservoir, Extension Feeding Set (With ENFit Connector, Without ENFit Connector), Enteral Syringes, and Others), By Age Group (Pediatric, and Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, and Others), By End User (Hospitals, Ambulatory Surgical Centres, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,260.6 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Some private and government agencies provide reimbursement for enteral feeding procedures, which include all the types of feeding tubes used in the feeding application.

Blue Cross Blue Shield Association is a federation of 36 separate U.S. health insurance companies that provide health insurance in the U.S. It provides medical coverage policy for enteral nutrition therapy.

BlueCHiP for Medicare and Commercial Products Coverage:

• Enteral nutrition therapy as the sole source of nutrition delivered by means of a nasogastric (NG), nasoenteric (NE), gastrostomy (G), or jejunostomy (J) feeding tube or through a vein is covered
• It also covers enteral or parenteral formulas which must be prescribed by a physician for use and administered by a home infusion therapy provider

Global Enteral Feeding Devices Market – Impact of Coronavirus (Covid-19) Pandemic

On April 01, 2020, the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition (ASPEN) reviewed and approved the guidelines and recommendation for the delivery of nutrition to critically ill COVID-19 patients. The recommendations provided by the organizations are given below.

Recommendation 1: Nutrition Assessment

The PPE (Personal Protective Equipment) standards provided by the Centers for Disease Control and Prevention (CDC) for patients with COVID-19 should be followed by all healthcare providers

Recommendation 2: Timing of Nutrition Delivery

Early enteral nutrition should be initiated within 24 to 36 hours of ICU admission and parenteral nutrition should be given only to patients who are at high risk and are not feasible for enteral nutrition

Recommendation 3: Route, Tube Placement and Method of Nutrition Delivery

Enteral nutrition should be preferred over parenteral nutrition. If the patient is suffering from gastrointestinal symptoms, early use of parenteral nutrition is recommended and enteral nutrition should be provided after symptoms subside.

 Recommendation 4: Nutrition Dose, Advancing to Goal, and Adjustments

Low dose enteral nutrition (hypocaloric or trophic) should be initiated, and advance to full dose enteral nutrition during the first week of critical illness.

Recommendation 5: Formula Selection

During the early acute phase of critical illness, a standard high protein polymeric isosmotic enteral formula is recommended.

Recommendation 6: Monitoring Nutrition Tolerance

Patients should be monitored by daily physical examination and confirmation of passing of gas and stool, as enteral feeding intolerance is very common during the early and late acute phases of critical illness.

Browse 44 Market Data Tables and 38 Figures spread through 218 Pages and in-depth TOC on “Enteral Feeding Devices Market”- Global Forecast to 2027, By Product Type (Feeding Tubes (Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube (Nasojejunal, Nasoduodenal), Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector (PEG (Percutenous Endoscopic Gastrostomy) Tube, PRG (Percutaneous Radiologic Gastrostomy) Tube, Button Tubes), Jejunostomy Tubes (PEJ (Percutaneous Endoscopic  Jejunostomy) Tube, PRJ (Percutaneous Radiologic Jejunostomy) Tube), Feeding Pumps (Peristaltic Silicone), Administration Reservoir, Extension Feeding Set (With ENFit Connector, Without ENFit Connector), Enteral Syringes, and Others), By Age Group (Pediatric and Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, and Others), By End User (Hospitals, Ambulatory Surgical Centres, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global enteral feeding devices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/enteral-feeding-devices-market-392

The increasing prevalence of malnutrition is expected to propel growth of the global enteral feeding devices market over the forecast period. For instance, according to the State of Palestine, Humanitarian Situation Report, January-June 2019, by the United Nations Children's Fund (UNICEF), around 18% of pregnant women and 14% lactating mothers in Gaza were malnourished and only 14% of children under 5 years of age had minimum acceptable diet in Gaza, in 2019.

Key Takeaways of the Global Enteral Feeding Devices Market:

• The global enteral feeding devices market is expected to exhibit a CAGR of 5.8% over the forecast period, owing to increasing incidences of chronic diseases such as cancer which is expected to drive the market growth over the forecast period. According to the European Commission reports in 2019, the estimated number of new cancer cases in 28 European countries was 1.6 million in males and 1.4 million in females.
• Among product type, feeding tubes segment accounted for the largest market share in 2020, owing to increasing number of central nervous system and mental health disorders which is expected to increase demand for feeding tubes. According to a recently published research 2019, neurological disorder is the second leading cause of approximately 9 million deaths, worldwide.
• Key players operating in the global enteral feeding devices market include Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Amsino International Inc., Applied Medical Technology, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Moog, Inc., Vygon S.A, Dynarex Corporation, and Medela AG.